1. Cochran RR, Starkey TD, Panos AL, Kunzelman KS: Ambulatory intraaortic balloon pump use as bridge to heart transplant. Ann Thorac Surg74:746-751, 2002.
2.
2. Jeevandandam V, Jayakar D, Anderson AS, Martin S, et al: Circulatory assistance with a permanent implantable IABP: Initial human experience. Circulation106(12 suppl 1):1183-1188, 2002.
3.
3. Hollenberg SM: Cardiogenic shock. Crit Care Clin17:391-410, 2001.
4.
4. Tennyson H, Kern KB, Hilwig RW, Berg RA, et al: Treatment of post resuscitation myocardial dysfunction: Aortic counterpulsation versus dobutamine. Resuscitation54:69-75, 2002.
5.
5. Barron HV, Everey NR, Parsons LS, Angeja B, et al: The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2. Am Heart J141:933-939, 2001.
6.
6. Papaioannou TG, Mathioulakis DS, Nanas JN, Tsangaris SG, et al: Arterial compliance is a main variable determining the effectiveness of intra-aortic balloon counterpulsation: Quantitative data from an in-vitro-study. Med Eng Phys24:279-284, 2002.
7.
7. Marra C, de Santo LS, Amarelli C, della Corte A, et al: Coronary artery bypass grafting in patients with severe left ventricular dysfunction: A prospective randomized study on the timing of perioperative balloon pump support. Int J Artif Organs25:141-146, 2002.
8.
8. Kang N, Edwards M, Larbalestier R: Preoperative intraaortic balloon pumps in high-risk patients undergoing openheart surgery. Ann Thorac Surg72:54-57, 2001.
9.
9. Hetzer R, Mueller JH, Weng Yu-go, Meyer R, et al: Bridging-to-recovery. Ann Thorac Surg71:5109-5113, 2001.
10.
10. Westaby S, Frazier OH, Beyersdorf E, Saito S, et al: The Jarvik 2000 Heart. Clinical validation of the intraventricular position. Eur J Cardiothorac Surg22:228-232, 2002.
11.
11. Kollar A, Misra V, Pierson RN 3rd: Postoperative coronary revascularization on LVAD support for inaccessible myocardial ischemia. Catheter Cardiovasc Interv55:381-384, 2002.
12.
12. Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, et al: Predictors of severe right ventricular failure after implantable left ventricular device insertion. Circulation106(suppl 1):I-198-I-202, 2002.
13.
13. Heerdt PM, Schlame M, Jehle R, Barbone A, et al: Diseasespecific remodelling of cardiac mitochondria after a left ventricular assist device. Ann Thorac Surg73:1216-1221, 2002.
14.
14. Chen X, Piacentino V 3rd, Furukawa S, Goldman B, et al: Ltype Ca2+ channel density and regulation are altered in failing human ventricle myocytes and recover after support with mechanical assist devices. Circ Res91:517-524, 2002.
15.
15. Vatta M, Stetson SJ, Perz-Verdia A, Entman ML, et al: Molecular remedeblgof dystrophin inpatients with endstage cardiomyopathy and reversal in patients on assistdevice therapy. Lancet359:936-934, 2002.
16.
16. de Jonge N, van Wichen DF, Schipper ME, Lapohr JR, et al: Left ventricular assist device in end-stage heart failure: Persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments. J Am Coll Cardiol39:963-969, 2002.
17.
17. Mann DL, Taegtmeyer HT: Dynamic regulation of the extracellular matrix after mechanical unloading of the failing human heart. Circulation104:1089-1091, 2001.
18.
18. Li YunYou, Feng Y, McTiernan ChF, Pei W, et al: Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation104:1147-1152, 2001.
19.
19. Loebe M, Koster A, Sanger S, Potapov EV, et al: Inflammatory response after implantation of a left ventricular assist device: Comparison between the axial flow MicroMed deBakey VAD and the pulsatile Novacor Device. ASAIO47:272-274, 2001.
20.
20. Koster A, Loebe M, Hansen R, Potapov EV, et al: Alterations in coagulation after implantation of pulsatile Novacor LVAD and the axial flow MicroMed DeBakey LVAD. Ann Thorac Surg70:533-537, 2000.
21.
21. Livingston ER, Fisher CA, Bibidakis EJ, et al: Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation94(9 suppl):II-227-II-234, 1997.
22.
22. Morsink PL, Verkerke GJ, Grootenboer HJ, Mihaylov D, et al: Numerical modelling of blood flow behaviour in the valved catheter of the PUCA-pump, a LVAD. Int J Artif Organs20:277-284, 1997.
23.
23. Verkerke GJ, Geertsema M, Mihaylov D, et al: Numerical simulation of the influence of a left ventricular assist device on the cardiovascular system. Int J Artif Organs23:765-773, 2000.
24.
24. de Jonge KC, Laube HR, Dohmen PM, Ivancevic V, et al: Diagnosis and management of left ventricular assist device valve endocarditis LVAD valve replacement. Ann Thorac Surg 70:1404-1405, 2000.
25.
25. Rose AG, Park SJ, Bank AD, Miller LW: Partial aortic valve fusion induced by left ventricular assist device. Ann Thorac Surg70:1270-1274, 2000.
26.
26. Menasche PH, Hagege M, Scorsin G, Pouzet B, et al: Myoblast transplantation for heart failure. Lancet357:279-280, 2001.
27.
27. Vetter FJ, McCulloch AD: Three-dimensional stress and strain in passive rabbit left ventricle: A model study. Ann Biomed Eng28:781-792, 2000.
28.
28. Schreuder JJ, Steendijk R, van der Veen FH, Alfieri O, et al: Acute and short-term effects of partial left ventriculotomy in dilated cardiomyopathy: Assessment by pressure-volume loops. J Am Coll Cardiol36:2104-2114, 2000.
29.
29. Konertz W, Dushe S, Hotz H, Braun JR, et al: Safety and feasibility of a cardiac support device. J Card Surg16:113-117, 2001.
30.
30. Arts T, Bovendeerd R, Delhaas T, Prinzen F: Modeling the relation between cardiac pump function and myofiber mechanics. Ann Biomed Eng [in press].
